Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 1b/2 study of derazantinib as monotherapy and combination therapy with paclitaxel, ramucirumab or atezolizumab in patients with HER2-negative gastric adenocarcinoma harboring FGFR genetic aberrations (FIDES-03)
Frentzas, Sophia
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
13/01/21
→
12/01/26
View all
View less
Keywords
phase 1 and 2 study
treatment efficacy
treatment safety
cancer treatment